Immune Profile and MRI-Detected Cardiac Fibrosis and Edema in Hypertensive and Non-Hypertensive Patients with COVID-19
Cardiac involvement in 2019 coronavirus disease (COVID-19) survivors has been reported frequently. An exacerbated immune response may be the main mechanism of myocardial injury and late cardiac sequelae in this population. Background/Objectives: We investigated the immune profile in hypertensive and non-hypertensive patients with COVID-19 who developed late cardiac fibrosis and edema, as detected by magnetic resonance imaging (MRI). Methods: We evaluated associations of cytokine and immune-cell subset levels during hospitalization for COVID-19 with the presence of myocardial interstitial fibrosis [represented by the extracellular volume (ECV)] or edema (represented by the T2), detected by cardiac MRI examination after discharge, in hypertensive and non-hypertensive patients. Results: Patients with hypertension had reduced B-cell percentages, increased natural killer cell percentages, and higher interleukin (IL)-4, IL-5, IL-13, IL-17A, and tumor necrosis factor-β levels compared to patients without hypertension. Larger percentages of human leukocyte antigen DR isotope+ blood cells, reflecting CD8+ T-cell activation, correlated with increased T2 and ECV in hypertensive patients. The HLA-DR mean fluorescence intensity was associated with ECV in non-hypertensive patients. Conclusions: Our findings reveal cytokine and immune-cell dysregulation in both hypertensive and non-hypertensive patients with COVID-19, along with moderate correlations between CD8+ T-cell activation and increased cardiac MRI markers of myocardial interstitial fibrosis and edema. These results contribute to a deeper understanding of immune dysfunction mechanisms involved in myocardial remodeling.
Citação
@online{renata2024,
  author = {Renata , Moll-Bernardes and Gabriel C. , Camargo and Andréa
    , Silvestre-Sousa and Julia Machado , Barroso and Juliana R. ,
    Ferreira and Mariana B. , Tortelly and Adriana L. , Pimentel and Ana
    Cristina B. S. , Figueiredo and Eduardo B. , Schaustz and José
    Carlos P. , Secco and Sergio C. , Fortier and Narendra , Vera and
    Luciana , Conde and Mauro Jorge , Cabral-Castro and Denilson C. ,
    Albuquerque and Paulo H. , Rosado-de-Castro and Martha V. T. ,
    Pinheiro and Olga F. , Souza and Ronir R. , Luiz and Emiliano ,
    Medei},
  title = {Immune Profile and MRI-Detected Cardiac Fibrosis and Edema in
    Hypertensive and Non-Hypertensive Patients with COVID-19},
  volume = {13},
  number = {23},
  date = {2024-12-02},
  doi = {10.3390/jcm13237317},
  langid = {pt-BR},
  abstract = {Cardiac involvement in 2019 coronavirus disease (COVID-19)
    survivors has been reported frequently. An exacerbated immune
    response may be the main mechanism of myocardial injury and late
    cardiac sequelae in this population. Background/Objectives: We
    investigated the immune profile in hypertensive and non-hypertensive
    patients with COVID-19 who developed late cardiac fibrosis and
    edema, as detected by magnetic resonance imaging (MRI). Methods: We
    evaluated associations of cytokine and immune-cell subset levels
    during hospitalization for COVID-19 with the presence of myocardial
    interstitial fibrosis {[}represented by the extracellular volume
    (ECV){]} or edema (represented by the T2), detected by cardiac MRI
    examination after discharge, in hypertensive and non-hypertensive
    patients. Results: Patients with hypertension had reduced B-cell
    percentages, increased natural killer cell percentages, and higher
    interleukin (IL)-4, IL-5, IL-13, IL-17A, and tumor necrosis factor-β
    levels compared to patients without hypertension. Larger percentages
    of human leukocyte antigen DR isotope+ blood cells, reflecting CD8+
    T-cell activation, correlated with increased T2 and ECV in
    hypertensive patients. The HLA-DR mean fluorescence intensity was
    associated with ECV in non-hypertensive patients. Conclusions: Our
    findings reveal cytokine and immune-cell dysregulation in both
    hypertensive and non-hypertensive patients with COVID-19, along with
    moderate correlations between CD8+ T-cell activation and increased
    cardiac MRI markers of myocardial interstitial fibrosis and edema.
    These results contribute to a deeper understanding of immune
    dysfunction mechanisms involved in myocardial remodeling.}
}